Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

Here, we present results from a clinical trial employing a new vaccination method using dendritic cells (DCs) transfected with mRNA from allogeneic prostate cancer cell lines (DU145, LNCaP and PC-3). In all, 20 patients were enrolled and 19 have completed vaccination. Each patient received at least...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mu, L J, Kyte, J A, Kvalheim, G, Aamdal, S, Dueland, S, Hauser, M, Hammerstad, H, Waehre, H, Raabe, N, Gaudernack, G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2005
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361645/
https://ncbi.nlm.nih.gov/pubmed/16136047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602761
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak